Search companies or stocks...
KRYSKrystal Biotech, Inc.
At close · 28 Aug 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead…
Current stock price of Krystal Biotech, Inc. (KRYS) stock is $351.46. The stock price is -1.68% lower in the session. The intraday range can be seen from this page. Volume of Krystal Biotech, Inc. (KRYS) stock is 143.50K.
Last updated at 28 Aug 2026, 08:00 pm.
The stock price of Krystal Biotech, Inc. (KRYS) can change with earnings, company news, and overall market sentiment. Krystal Biotech, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Krystal Biotech, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KRYS on this page is 44.04. EPS on this page is 7.98. Compare those figures with peers and growth expectations before deciding if the current Krystal Biotech, Inc. price is justified.
Historical performance for Krystal Biotech, Inc. (KRYS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KRYS reacted to past earnings and market events.
Buying Krystal Biotech, Inc. (KRYS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
